Compounds > n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine
Page last updated: 2024-09-03

n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine and Alloxan Diabetes

n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Haan, BJ; De Vos, P; Van Schilfgaarde, R1

Other Studies

1 other study(ies) available for n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine and Alloxan Diabetes

ArticleYear
Factors causing failure of islets in nonovergrown capsules.
    Transplantation proceedings, 1998, Volume: 30, Issue:2

    Topics: 2-Naphthylamine; Animals; Biocompatible Materials; Capsules; Diabetes Mellitus, Experimental; Graft Rejection; Islets of Langerhans Transplantation; Rats; Rats, Inbred Lew

1998